Qitian Mu

742 total citations
61 papers, 370 citations indexed

About

Qitian Mu is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Qitian Mu has authored 61 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 30 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Qitian Mu's work include Acute Myeloid Leukemia Research (27 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Multiple Myeloma Research and Treatments (5 papers). Qitian Mu is often cited by papers focused on Acute Myeloid Leukemia Research (27 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Multiple Myeloma Research and Treatments (5 papers). Qitian Mu collaborates with scholars based in China and United States. Qitian Mu's co-authors include Jie Jin, Lixia Sheng, Guifang Ouyang, Qiuling Ma, Kaihong Xu, Mengxia Yu, Bixia Li, Shasha Lu, Shujun Yang and Yungui Wang and has published in prestigious journals such as Blood, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Qitian Mu

53 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qitian Mu China 11 209 127 96 62 61 61 370
Ajay Abraham United States 10 247 1.2× 172 1.4× 35 0.4× 68 1.1× 86 1.4× 30 389
Youwen Qin China 11 197 0.9× 118 0.9× 64 0.7× 51 0.8× 61 1.0× 25 344
Rudy Birsen France 11 247 1.2× 133 1.0× 123 1.3× 78 1.3× 78 1.3× 32 454
Lindsay Wilde United States 7 247 1.2× 78 0.6× 186 1.9× 28 0.5× 125 2.0× 42 455
Shenglan Gong China 11 286 1.4× 180 1.4× 36 0.4× 30 0.5× 118 1.9× 30 447
José González Spain 10 365 1.7× 297 2.3× 76 0.8× 37 0.6× 99 1.6× 25 507
Rabin Niroula United States 6 119 0.6× 120 0.9× 43 0.4× 44 0.7× 58 1.0× 23 284
Lidija Dokmanović Serbia 13 145 0.7× 114 0.9× 53 0.6× 61 1.0× 88 1.4× 47 419
Éric Grignano France 9 191 0.9× 146 1.1× 101 1.1× 88 1.4× 98 1.6× 23 452
Takanobu Morishita Japan 11 107 0.5× 100 0.8× 30 0.3× 43 0.7× 70 1.1× 37 268

Countries citing papers authored by Qitian Mu

Since Specialization
Citations

This map shows the geographic impact of Qitian Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qitian Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qitian Mu more than expected).

Fields of papers citing papers by Qitian Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qitian Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qitian Mu. The network helps show where Qitian Mu may publish in the future.

Co-authorship network of co-authors of Qitian Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Qitian Mu. A scholar is included among the top collaborators of Qitian Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qitian Mu. Qitian Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mu, Qitian, et al.. (2024). CAUSAL RELATIONSHIP BETWEEN HELICOBACTER PYLORI ANTIBODIES AND IMMUNE THROMBOCYTOPENIA: A MENDELIAN RANDOMIZATION STUDY. Mediterranean Journal of Hematology and Infectious Diseases. 17(1). e2025003–e2025003.
3.
Chen, Ying, Chao Ma, Jie Cao, et al.. (2024). Elevated serum direct bilirubin is predictive of a poor prognosis for primary myelodysplastic syndrome. BMC Cancer. 24(1). 1392–1392. 1 indexed citations
4.
Chen, Ying, Bixia Li, Shujun Yang, et al.. (2024). Circ_0012152 Accelerates Acute Myeloid Leukemia Progression through the miR-652-3p/SOX4 Axis. Current Medical Science. 44(3). 611–622. 1 indexed citations
5.
Sheng, Lixia, Tongyu Li, Yun Li, et al.. (2023). Prognostic and immunological characterization of diffuse large B-cell lymphoma evaluated by co-stimulatory molecular-related features. Heliyon. 9(9). e19342–e19342. 7 indexed citations
6.
Lv, Mei, Ying Chen, Chao Ma, et al.. (2023). Down-regulation of Musashi-2 exerts antileukemic effects on acute lymphoblastic leukemia cells and increases sensitivity to dexamethasone. Annals of Hematology. 103(1). 141–151. 1 indexed citations
7.
Wang, Jiaping, Yanli Zhang, Ping Zhang, et al.. (2023). Silencing of PD-1 combined with EBV-specific killer T cells for the treatment of EBV-associated B lymphoma. Translational Oncology. 40. 101831–101831.
8.
Mao, Dan, Jiaping Wang, Yanli Zhang, et al.. (2023). The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma. Frontiers in Immunology. 14. 1105293–1105293. 18 indexed citations
9.
Chen, Ying, Ting Chen, Cong Shi, et al.. (2023). Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome. Frontiers in Nutrition. 10. 1125768–1125768.
10.
Shi, Cong, et al.. (2022). The Prognostic Value of Pretherapy Peripheral Blood Inflammatory Indices in Myelodysplastic Syndromes. Frontiers in Oncology. 12. 877981–877981. 3 indexed citations
11.
He, Yiwen, Jun Liang, Guoqing Qian, et al.. (2021). Differential diagnosis of coronavirus disease 2019 pneumonia or influenza A pneumonia by clinical characteristics and laboratory findings. Journal of Clinical Laboratory Analysis. 35(2). e23685–e23685. 2 indexed citations
12.
Guo, Shanshan, Bixia Li, Ying Chen, et al.. (2020). Hsa_circ_0012152 and Hsa_circ_0001857 Accurately Discriminate Acute Lymphoblastic Leukemia From Acute Myeloid Leukemia. Frontiers in Oncology. 10. 1655–1655. 29 indexed citations
13.
Jiang, Danjie, Huiling Zhu, Yi Wang, et al.. (2019). Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia. Journal of International Medical Research. 47(4). 1483–1492. 8 indexed citations
14.
15.
Yan, Xiao, Miao Zhou, Zhongze Lou, et al.. (2018). Diffuse large B-cell lymphoma with concurrent hepatitis B virus infection in the MabThera era. Journal of Cancer Research and Therapeutics. 14(Suppl 1). S248–S253. 11 indexed citations
16.
Lai, Binbin, Qitian Mu, Yi Wang, et al.. (2018). Durable remission in a patient of mixed phenotype acute leukemia with Philadelphia chromosome-positive treated with nilotinib and lenalidomide. Medicine. 97(14). e0294–e0294. 6 indexed citations
17.
Wang, Wei, Zhimei Chen, Mengxia Yu, et al.. (2015). [Clinical and cytogenetic study of chromosome 1 abnormality in myelodysplastic syndrome].. PubMed. 36(10). 818–23. 1 indexed citations
18.
Mu, Qitian, Qiuling Ma, Shasha Lu, et al.. (2014). 10058-F4, a c-Myc inhibitor, markedly increases valproic acid-induced cell death in Jurkat and CCRF-CEM T-lymphoblastic leukemia cells. Oncology Letters. 8(3). 1355–1359. 11 indexed citations
19.
Ruan, Liemin, Honghua Ye, Yan‐Ru Lou, et al.. (2013). The change of peripheral blood endothelial progenitor cells in patients with newly diagnosed depression. Chin J Psychiatry. 46(5). 290–294. 1 indexed citations
20.
Mu, Qitian, Yungui Wang, Bing Chen, et al.. (2013). High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia. Leukemia Research. 37(8). 922–927. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ajay Abraham Breakdown of academic impact, for papers by Youwen Qin Breakdown of academic impact, for papers by Rudy Birsen Breakdown of academic impact, for papers by Lindsay Wilde Breakdown of academic impact, for papers by Shenglan Gong Breakdown of academic impact, for papers by José González Breakdown of academic impact, for papers by Rabin Niroula Breakdown of academic impact, for papers by Lidija Dokmanović Breakdown of academic impact, for papers by Éric Grignano Breakdown of academic impact, for papers by Takanobu Morishita
Rankless by CCL
2026